Wells Fargo’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-8,569
| Closed | -$645K | – | 7578 |
|
2022
Q2 | $645K | Sell |
8,569
-149,142
| -95% | -$11.2M | ﹤0.01% | 3374 |
|
2022
Q1 | $4.24M | Sell |
157,711
-1,204
| -0.8% | -$32.3K | ﹤0.01% | 2454 |
|
2021
Q4 | $7.58M | Sell |
158,915
-481,234
| -75% | -$23M | ﹤0.01% | 2010 |
|
2021
Q3 | $42.5M | Sell |
640,149
-7,035
| -1% | -$467K | 0.01% | 1142 |
|
2021
Q2 | $50.5M | Buy |
647,184
+8,047
| +1% | +$628K | 0.01% | 1035 |
|
2021
Q1 | $60.5M | Buy |
639,137
+7,637
| +1% | +$722K | 0.01% | 922 |
|
2020
Q4 | $76.9M | Buy |
631,500
+20,766
| +3% | +$2.53M | 0.02% | 759 |
|
2020
Q3 | $53.4M | Buy |
610,734
+109,081
| +22% | +$9.53M | 0.01% | 834 |
|
2020
Q2 | $32.4M | Buy |
501,653
+10,426
| +2% | +$673K | 0.01% | 1070 |
|
2020
Q1 | $21.9M | Sell |
491,227
-28,092
| -5% | -$1.25M | 0.01% | 1174 |
|
2019
Q4 | $32.3M | Sell |
519,319
-14,247
| -3% | -$887K | 0.01% | 1167 |
|
2019
Q3 | $20.1M | Buy |
533,566
+531,784
| +29,842% | +$20M | 0.01% | 1436 |
|
2019
Q2 | $72K | Buy |
+1,782
| New | +$72K | ﹤0.01% | 5176 |
|